Covington, KY-headquartered CTI is a global, privately held, full-service CRO.
Eurotrials operates within Europe and Latin America and provides various services from early- to late-stage research.
The acquisition strengthens CTI’s real-world evidence business, according to the company, in addition to expanding its global footprint.
Timothy J. Schroeder, CTI Founder and CEO explained in a press release that the move creates “one of the 20 largest CROs in the world.”
“We are excited to join our companies together to create a stronger full-service global clinical research organization,” he said.
As a unified company, it will span more than 30 countries across six continents.
The terms of the acquisition were not disclosed.
CTI has not responded to a request for comment as of publication.